Skip to content

Psychedelic-assisted therapy: all studies

Page 153 of 294: studies 1,521 to 1,530 of 2,936, newest first. Back to the psychedelic-assisted therapy overview

Research

The Research Deficit and Expert Disagreement Regarding Music Selection for Psychedelic Assisted Therapy.

ACS Pharmacology & Translational Science October 10, 2025 Milo Moskovitz 2 citations

Prior research has determined that music plays a central role in psychedelic assisted therapy (PAT). While there is a general consensus of the importance of music during PAT, there are only three empirical studies published to date that directly investigate which type of music might best support PAT. Importantly, no review to date has critically analyzed these studies and identified the gaps....

Questions and Concerns About MDMA-Assisted Therapy (MDMA-AT) in Veterans with PTSD Symptoms

Journal of Psychoactive Drugs October 10, 2025 Mitch Earleywine, Caitlin Holley, Henry A MacConnel et al.

MDMA-assisted therapy (MDMA-AT) for post-traumatic stress disorder (PTSD) shows promise, but attitudes and beliefs about this treatment, especially in symptomatic veterans, remain poorly understood. We sought to explore relevant attitudes in veterans receiving healthcare from Veterans Affairs as a step toward designing relevant surveys or psychoeducation materials for future work. We employed a...

DOI: 10.1080/02791072.2025.2570938 (opens in new tab) Anxiety Psychoeducation Curiosity Narrative +11

LSD: Mechanisms and relevance to the treatment of depression

Neuroscience & Biobehavioral Reviews October 10, 2025 Amel Bouloufa, Sarah Delcourte, Thomas Delannay et al. 3 citations

Major depressive disorder (MDD) is one of the most prevalent psychiatric conditions worldwide, affecting over 350 million people. Standard treatments, primarily antidepressants targeting serotonin, noradrenaline, and/or dopamine, are based on the monoamine hypothesis, which links depression to imbalances in these neurotransmitters. A sizable fraction of patients, however, does not get enough...

Psilocybin’s effect on human brain synaptic plasticity

Research Square October 10, 2025 Gitte M. Knudsen, Annette Johansen, Pontus Plavén-sigray et al. preprint

Abstract Psychedelics such as psilocybin have been linked to enhanced neuroplasticity and symptom relief in affective disorders, but the neurobiological mechanisms and impact of environmen-tal context remain unclear. Here, we tested whether a single dose of psilocybin alters synap-tic density in healthy individuals and whether setting-dependent subjective experience shapes this effect. Fifteen...

Stabilizing Psilocybin Pharmacology and Tuning Safety with Atypical Antipsychotic Cotherapy

ACS Medicinal Chemistry Letters October 10, 2025 Anna C. Renner, Robert B. Kargbo

A crystalline cocrystal of psilocin and psilocybin enhances exposure, neuroplasticity biomarkers, and functional activity, while adjunctive atypical antipsychotics modulate serotonergic signaling to mitigate 5-HT2B-linked safety concerns. Together, these inventions advance formulation, mechanistic selectivity, and translational biomarkersoffering a chemistry-enabled path to scalable...

Toward Precision Psychedelic Therapies: Chemical, Computational, and Neuromodulatory Innovations.

ACS Medicinal Chemistry Letters October 9, 2025 Anna C. Renner, Robert B. Kargbo

Recent patents disclose complementary strategies to optimize psychedelic-assisted therapy. Novel psilocin prodrugs improve pharmacokinetics and stability, while digital systems enable cognitive state monitoring during treatment. Parallel advances in combining neuroplastogen drugs with transcranial electrical stimulation highlight a model-driven approach to enhance and personalize neural...

Examining Volunteer Bias in Psychedelic Research.

Journal of Psychoactive Drugs October 8, 2025 Samantha G. Gomez, Fiona Low, Mitch Earleywine

Since its resurgence, psychedelic research has garnered considerable attention, especially in mental health. Preliminary findings have indicated positive results regarding psychedelic-assisted psychotherapy. Despite promising findings, various researchers have voiced concerns regarding psychedelic research and its potential for volunteer bias. Participants willing to participate in clinical...

DOI: 10.1080/02791072.2025.2570936 (opens in new tab) Full text (opens in new tab) Psychedelic research Diversity Generalizability Inclusion +2

USO TERAPÊUTICO DA PSILOCIBINA: REVISÃO INTEGRATIVA

Revista fisio&terapia October 8, 2025 Maurício Pedro Luciano da Costa, Pedro Bruschi Peiretti, Pedro Vinicius Rodrigues Silveira Silva et al.

A resurgence of scientific and clinical interest in psychedelic-assisted therapies, particularly with Psilocybin, has been observed. This paper presents an integrative literature review aiming to identify the scientific contributions, potential benefits, and limitations of the therapeutic use of psilocybin in mental health. The study followed a rigorous protocol. Searches were conducted in the...

Psicoterapia assistida por cetamina no tratamento da depressão resistente

Revista Eletrônica Acervo Científico October 7, 2025 Tainá Zen Loss, Carolina Radaelli Fucina, Denise Bergamo Schenato et al.

Objetivo: Analisar a evidência clínica e o racional neurobiológico do uso da cetamina assistida por psicoterapia no tratamento da depressão resistente. Revisão bibliográfica: A depressão resistente ao tratamento (DRT) caracteriza-se pela persistência de sintomas depressivos após falha em pelo menos dois tratamentos antidepressivos adequados, associando-se a prejuízos funcionais, sofrimento...

DOI: 10.25248/reac.e21871.2025 (opens in new tab) Palliative care Medical treatment Gynecology Intensive care medicine +1

On psychedelic liberalism and mad trust: towards varieties of willing in extreme experiences

Biosocieties October 4, 2025 Tehseen Noorani

Abstract The vexed ‘psychotomimetic model’ of psychedelics claims to offer insights into both psychedelic experiences and psychosis, by weaving across these sets of experiences. One enduring opposition to the model distinguishes between psychedelic experiences as voluntary or ‘willed’, and psychosis as an affliction to be endured. This opposition is useful for projects seeking to sanitise and...

DOI: 10.1057/s41292-025-00368-z (opens in new tab) Full text (opens in new tab) Opposition politics Phenomenology philosophy Liberalism Undoing +6